BioDelivery Sciences signs deal with nonprofit group

01/26/2009 | Pharmaceutical Business Review Online

BioDelivery Sciences International has agreed to work with the nonprofit Drugs for Neglected Diseases initiative in testing the safety and efficacy of Bioral Amphotericin B, a treatment for leishmaniasis, Chagas' disease and other communicable diseases. Bioral Amphotericin B uses BDSI's patented Bioral drug delivery technology to allow the drug to be administered orally rather than intravenously.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT